Matthew Bell Institution Verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
Matthew Bell's research focuses on the study of immune cells and inflammatory processes, particularly in the context of inflammatory bowel disease. His work has investigated the role of specific proteins, such as carboxylesterase-1 and BET proteins, in modulating inflammatory pathways. Bell has explored the therapeutic potential of BET protein inhibitors targeting mononuclear myeloid cells for Crohn's disease, examining their effects on inflammatory mediators and pathways. Additionally, his research has delved into the epigenetic regulation of immune cells, studying how proteins like SP140 influence dendritic cell function.
Bell's publications also include work on rare pediatric neurological disorders, such as trofinetide-induced enterocolitis syndrome in children with Rett syndrome. He has been involved in clinical studies evaluating the safety and efficacy of novel therapeutic agents, including oral BET inhibitors in Phase 1 trials. His scholarship metrics indicate an h-index of 9 with 782 total citations across 15 publications, and he has collaborated with researchers at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 9
- Publications: 15
- Citations: 782
Selected Publications
- Trofinetide-Induced Enterocolitis Syndrome in a Child with Rett Syndrome (2025) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics